Psychedelic Therapeutics & Drug Development Conference

Boston, MA, United States | 23 May 2024 - 24 May 2024

Home
Events
Psychedelic Therapeutics & Drug Development Conference

Overview

Connect with Quotient Sciences at the Psychedelic Therapeutics & Drug Development Conference.

This event will highlight the progress being made towards regulatory approval of a variety of psychedelics with the potential to treat various conditions, including inflammatory/autoimmune disorders, brain injury, pain, PTSD, anxiety, ADHD, headaches, depression, and opioid use disorder.

Visit us at this event and talk with one of our experts.

If you would like to arrange dedicated time to speak with us, please complete the form below.

Request a Meeting

Location

Revere Hotel Boston Common

200 Stuart Street

Boston, MA, United States

Meet our expert:

We look forward to meeting you at the Psychedelic Therapeutics & Drug Development Conference in Boston.

Daniel Dennehy

Director Of Business Development

Dan is an accomplished Business Development Director with over 10 years of experience in sales to healthcare, pharmaceutical, and ...

More insight from our experts:

Oncology, Translational Pharmaceutics, Dr. Paul Quigley Insight from our experts: How Translational Pharmaceutics accelerates oncology clinical trials By: Dr. Paul Quigley

Oncology, Translational Pharmaceutics, John McDermott A Smarter Strategy for Optimizing Oncology Drug Products By: John McDermott

Translational Pharmaceutics, Dr. Vanessa Zann Scientific Poster Spotlight: Applications of Lipid-based Formulations and the Benefits of Integrating Manufacturing and Clinical Testing in Formulation Selection By: Dr. Vanessa Zann